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ABSTRACT
BACKGROUND AND PURPOSE: The use of invasive cerebral angiography with CTA for active treatment of patients with suspected
ischemic strokes has been increasing recently. This study aimed to identify the incidence of postcontrast acute kidney injury using
baseline renal function when CTA and cerebral angiography were performed sequentially.
MATERIALS AND METHODS: This retrospective observational study evaluated adults (18 years of age or older) with ischemic stroke
who underwent CTA and cerebral angiography sequentially between 2010 and 2018. The incidence of postcontrast acute kidney
injury was determined using the baseline estimated glomerular filtration rate. The value of the baseline estimated glomerular filtra-
tion rate at which the occurrence of postcontrast acute kidney injury increased was also determined.
RESULTS: Postcontrast acute kidney injury occurred in 57/601 (9.5%) patients. Those with a baseline estimated glomerular filtration
rate of ,30mL/min/1.73 m2 showed a higher incidence of acute kidney injury. Age, chronic kidney disease, medication (nonsteroidal
anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, b blockers, statins, and insulin) use
following contrast media exposure, and serum albumin affected the incidence of postcontrast acute kidney injury. The incidence of
postcontrast acute kidney injury increased when the baseline estimated glomerular filtration rate was ,43mL/min/1.73 m2.
CONCLUSIONS: Patients with low baseline renal function had the highest incidence of postcontrast acute kidney injury after CTA
and cerebral angiography, but no fatal adverse effects were documented. Thus, patients suspected of having a stroke should be
actively managed with respect to neurovascular function.
ABBREVIATIONS: AKI ¼ acute kidney injury; ED ¼ emergency department; eGFR ¼ estimated glomerular filtration rate; PC-AKI ¼ postcontrast acute kidney
injury
Acute ischemic stroke requires active management in theemergency setting to prevent long-term sequelae and curb
mortality.1,2 The recently published 2018 American Heart
Association/American Stroke Association guidelines for early
treatment of stroke recommend endovascular recanalization after
6 hours of symptom onset, shifting the focus to a more active and
invasive approach.3 The guidelines also recommend CTA to
improve diagnosis, aid in the treatment of acute ischemic cerebral
infarction, and assist patient selection in interventional radiology
on the basis of the head and neck vascular status4,5—that is, once
a CTA is performed, on the basis of the time of neurologic symp-
tom onset and its severity, there is a high probability of active
intervention with intra-arterial thrombolysis via cerebral angiog-
raphy for early reperfusion.6-8
However, the incidence of postcontrast acute kidney injury
(PC-AKI) is expected to increase in such conditions because of
patient exposure to approximately 200mL of contrast media in a
short time.9,10 PC-AKI can lead to irreversible kidney damage
and an increased risk of morbidity and mortality, particularly
because no established treatments are available. Therefore, there
is a need for emergency department (ED) personnel to perform
evidence-based risk/benefit assessment for performing CTA
and cerebral angiography in patients with suspected ischemic
strokes.9-11
Previous studies have drawn conflicting conclusions on the
risk factors associated with PC-AKI.12-14 Even though there are
studies on PC-AKI after either CTA or cerebral angiography,
studies that consider concomitant CTA and cerebral angiography
performed within a short duration are lacking.10,11 In addition,
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there is scant literature on the occurrence of PC-AKI according
to the baseline renal function. Furthermore, there are no clear
guidelines on the use of contrast media in patients with renal dis-
ease.1,15-17
Therefore, this study aimed to identify the incidence of PC-
AKI in terms of the baseline renal function in patients who
underwent both CTA and cerebral angiography for suspected is-
chemic stroke in the ED. Furthermore, we aimed to present a ref-
erence value of the baseline of the estimated glomerular filtration
rate (eGFR) that increases the likelihood of PC-AKI, to serve as a
basis for decision-making in the ED.
MATERIALS AND METHODS
Ethics
The institutional review board of Yonsei University Health
System Clinical Trial Center approved the study (approval num-
ber, 4–2019–0170) and waived the requirement for informed
consent on the basis of the retrospective observational study
design. The study was conducted according to the tenets of the
Declaration of Helsinki as revised in 2013.
Study Design and Population
This retrospective study was conducted using data from patients
enrolled in the Brain Salvage through Emergent Stroke Therapy
critical pathway protocol implemented at our tertiary university
hospital in Seoul, South Korea. The necessary data for the study
were collected from the electronic medical records.
We evaluated data of adult patients (18 years of age or older)
who visited the ED between October 2010 and September 2018
and underwent both CTA and cerebral angiography for differen-
tiation and treatment of ischemic stroke, respectively. The exclu-
sion criteria were the following: 1) CTA performed at another
hospital or not performed, 2) death within 48 hours of CTA, 3)
transfer or discharge within 48hours of CTA, 4) CTA and cere-
bral angiography performed at an interval longer than 48 hours,
5) the presence of end-stage renal disease, and 6) no serum creati-
nine data within 72hours of contrast media use.
Brain Salvage through Emergent Stroke Therapy Protocol
The Brain Salvage through Emergent Stroke Therapy critical
pathway is a medical process protocol implemented by the ED to
perform rapid thrombolytic therapy for patients with suspected
acute ischemic stroke. This protocol identifies patients with
symptoms indicative of stroke, such as single-sided weakness,
speech disorder, gait disturbance, loss of consciousness, visual
field symptoms, and sudden headache. Once the critical pathway
is activated by an ED physician, a neurologist examines the
patient and CTA is performed subsequently. Thrombolytic ther-
apy through cerebral angiography is performed in the angiogra-
phy suite as necessary.
CTA
All imaging was performed using a high-resolution CT scanner
(Revolution EVO; GE Healthcare, Milwaukee, Wisconsin).
For CTA, isotonic contrast material (iopamidol 755mg/mL,
Iopamiro 370; Bracco, Milan, Italy) was injected at a rate of
4 mL/s. The upper limit volume of the contrast material was
100mL.
Cerebral Angiography
Cerebral angiography was performed on an angiography system
(Allura Clarity FD 20/20; Philips Healthcare, Best, the Netherlands).
For cerebral angiography, isotonic contrast material (iodixanol
652mg/mL, Visipaque 320; GE Healthcare) was injected at a rate of
3–4mL/s.
Definition of Exposure and Outcome
In this study, the eGFR was calculated using the Chronic Kidney
Disease Epidemiology Collaboration equation (https://www.
kidney.org/content/ckd-epi-creatinine-equation-2009), according
to the current guidelines. The enrolled patients were then divided
into 4 groups based on eGFR (milliliters/minute/1.73 m2) values
that increase the risk of PC-AKI as follows: eGFR ,30, eGFR
30–59, eGFR 60–89, and eGFR$90.18 Although there are diverse
definitions of PC-AKI, we used the absolute increase in serum
creatinine levels by $0.5mg/dL or a relative increase in serum
creatinine levels by $25% from baseline observed within
72 hours after contrast media exposure as proposed by Barrett
and Parfrey.19
Statistical Analysis
Post hoc analyses were performed to determine the PC-AKI inci-
dence according to the baseline eGFR groups. In addition, uni-
variate logistic analysis was performed to determine the impact of
each variable on PC-AKI occurrence. Statistically significant vari-
ables in the univariate logistic analysis were subjected to multi-
variable logistic regression analysis through a stepwise variable
selection to determine independent variables. Subsequently, the
baseline eGFR cutoff value was determined using the maximum
area under the curve. All statistical analyses were performed using
SAS, Version 9.4 (SAS Institute, Cary, North Carolina), and P val-
ues, .05 were considered statistically significant.
RESULTS
Of the 726 patients identified, 125 patients were excluded. Thus,
601 patients were included in the analysis. PC-AKI occurred in
57 (9.5%) patients (Fig 1). In total, 15 (2.5%) patients had an
eGFR of ,30mL/min/1.73 m2; 97 (16.14%) patients, eGFR of
30–59mL/min/1.73 m2; 302 (50.25%) patients, eGFR of 60–
89mL/min/1.73 m2; and 187 (31.11%) patients, eGFR of
$90mL/min/1.73 m2. The incidences of PC-AKI significantly
differed among the baseline eGFR groups (P, .001) (Table 1).
Post hoc analysis showed that the group with an eGFR of
,30mL/min/1.73 m2 had a higher PC-AKI incidence than the
other groups, and the differences in incidences among the
remaining groups were not significant (Table 2).
In the univariate analyses, the significant risk factors (all
P, .05) for PC-AKI were age older than 75 years, diabetes melli-
tus, chronic kidney disease, atrial fibrillation, use of angiotensin-
converting enzyme inhibitors and angiotensin II receptor block-
ers before CTA, medication (nonsteroidal anti-inflammatory
drugs, angiotensin-converting enzyme inhibitors, angiotensin II
receptor blockers, b blockers, statins, and insulin) use after
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contrast exposure, proteinuria, low hemoglobin and hematocrit
levels, a high D neutrophil index, low platelet count, low serum
albumin level, and low sodium concentration. In the multivariate
model, age older than 75 years, chronic kidney disease, medica-
tion (nonsteroidal anti-inflammatory drugs, angiotensin-convert-
ing enzyme inhibitors, angiotensin II receptor blockers, b
blockers, statins, insulin) use after contrast exposure, and serum
albumin levels were found to significantly (all P, .05) influence
the occurrence of PC-AKI (On-line Table).
The maximum area under the curve value in the receiver
operating characteristic curve analysis was obtained for the varia-
bles, and the baseline eGFR value corresponding to the maximum
area under the curve value was identified. The resulting cutoff
value of baseline eGFR was found to be 43mL/min/1.73 m2
(Fig 2). This value retained significance in the univariate analysis.
DISCUSSION
Patients with acute ischemic stroke who visit the ED have high
short-term mortality rates (16%–23%).20,21 Even mild ische-
mic stroke is associated with poor prognosis during long-
term follow-up.22 Therefore, rapid and accurate diagnosis
and treatment of ischemic stroke are essential in the ED for
such patients. Noncontrast brain CT has been used as a stand-
ard test in the evaluation of patients with acute stroke because
of the short amount of time required, its convenience, and
wide availability at many hospitals.23
The recently updated American Heart
Association/American Stroke As-socia-
tion guidelines recommend endovascu-
lar recanalization therapy for patients
with suspected stroke arriving at the
ED after 6 hours of symptom onset. In
line with aggressive treatment, CTA is
a tool optimized for cerebral angio-
graphic treatment with the advantage
of rapidly detecting cerebrovascular
large-vessel occlusion with high accu-
racy in the emergency department.24
However, concomitant use of CTA
and cerebral angiography exposes the
patient to excessive contrast media in a
short time. This can be burdensome to
not only the patient but also the physi-
cians. To date, studies on contrast media administration and acute
kidney injury (AKI) incidence have reported diverse results
according to the underlying diseases and general patient condi-
tion. Furthermore, studies that include cases with simultaneous
contrast media use for diagnosis and treatment are lacking.
The task of accurately predicting contrast-induced kidney
injury in patients with suspected stroke who require rapid man-
agement in the ED could likely delay the decision-making by
neurologists and ED physicians.12-14 Therefore, presenting
grounds for treatment that can be the criteria for judgment by
ED physicians can be very important. Recently, Jia et al9 reported
no significant difference in the incidence of PC-AKI between
CTA only and with a combination of CTA and DSA. However,
this study with a small sample size did not control for factors that
affect AKI. In the present study, the PC-AKI incidence was com-
pared among groups classified according to baseline eGFR with-
out any adjustments. PC-AKI occurred in 7/15 (46.6%) patients
in the group with an eGFR of,30mL/min/1.73 m2, and the inci-
dence of PC-AKI was also significantly higher in this group com-
pared with the other groups. This result was similar to the results
of other previous studies.25 However, this result was judged to be
inaccurate because the patients’ underlying medical conditions
were not considered. Therefore, the risk factors of AKI other
than the contrast medium were determined and adjusted for to
determine the cutoff value of eGFR at which the risk of AKI
occurrence increases. We found that when CTA and cerebral
angiography were performed consecutively, the probability of
PC-AKI occurrence increased when the baseline eGFR was
,43mL/min/1.73 m2.
However, this result cannot be an absolute guideline to pre-
vent examinations that are indispensable due to the risk of PC-
AKI in patients with eGFR ,43mL/min/1.73 m2. In fact, con-
tinuous renal replacement therapy was performed in only
5/57 patients (8.7%) with PC-AKI, corresponding to only
0.8% of the 601 patients evaluated. All 5 patients fully recov-
ered within 4 days of continuous renal replacement therapy.
In addition, the renal function of the remaining patients who
developed PC-AKI but did not undergo hemodialysis or con-
tinuous renal replacement therapy also recovered within
Table 2: Post hoc analysis for comparison of PC-AKI incidence
between baseline eGFR groups
Adjusted P
1 vs 2 1 vs 3 1 vs 4 2 vs 3 2 vs 4 3 vs 4
.001 .005 ,.001 ..999 ..999 .349
FIG 1. Patient inclusion flowchart. ESRD indicates end-stage renal disease.
Table 1: PC-AKI incidence based on baseline eGFRa
Group eGFR (mL/min/1.73 m2) Non-AKI PC-AKI P
1 ,30 8 (1.47) 7 (12.28) ,.001
2 30–59 91 (16.73) 6 (10.53)
3 60–89 269 (49.45) 33 (57.89)
4 $90 176 (32.35) 11 (19.30)
a Data are number of patients and percentage.
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several days. Therefore, in this study, even when PC-AKI
occurred, its degree was not severe. Hence, the treatment deci-
sions must be according to the neurologic symptoms and
patient status. However, on the basis of the significant varia-
bles noted in the univariate analysis, physicians can predict
patients at high risk of PC-AKI. Therefore, physicians will be
able to perform sufficient IV hydration for these patients and
plan an individual nephron-protective strategy for each
patient.26,27 This process will enable performance of relevant
tests after sufficiently explaining the predictable results to
patients and their caregivers and is expected to be helpful in
clinical practice.
The strength of this study is that data on various factors
known to be related to PC-AKI were collected from patients
treated using the Brain Salvage through Emergent Stroke
Therapy critical pathway protocol that has been implemented
consistently for a long time at a single institution. Many studies
on the relationship between contrast media and renal diseases
exist. However, to the best of our knowledge, this is the first
study to identify the relationship between contrast media and
AKI based on the baseline eGFR in patients who undergo
CTA and cerebral angiography sequentially within a short
interval. Furthermore, the cutoff value of eGFR for predicting
PC-AKI was calculated with adjustment for various factors
associated with PC-AKI. These results can be helpful for
accurate treatment planning. Moreover, our findings will be
valuable in the prevention of AKI because the cutoff values of
eGFR presented here can be used to identify patients at high
risk for PC-AKI, which, in turn, will enable physicians to pro-
vide individualized treatment.
However, our study has several limitations. Because this study
was conducted at a single center, the results may have limited
generalizability. Due to the retrospective design of the study,
selection biases may have occurred because in some cases, labora-
tory data for creatinine levels after CTA and cerebral angiography
were missing. Furthermore, additional biases owing to seriously
ill patients who died within 48hours after the examinations and
those who were discharged or transferred within 48 hours for
other reasons not included in the study may also exist. In our
study, the postcontrast exposure to medication can also be
thought of as a confounder because the more severe the disease
state of the patient is, such as in patients with PC-AKI, the more
medication is prescribed after contrast exposure. In addition, for
patients with an extremely low baseline eGFR, cerebral angiogra-
phy was performed after noncontrast brain CT without perform-
ing CTA, and there is a possibility that this feature may have
affected the results to some extent. Finally, the area under the
curve after adjustment for risk factors in this study was 0.7310,
indicating that PC-AKI is influenced by more risk factors.
Therefore, our findings need to be validated in future studies.
Last, because PC-AKI is affected by many variables, AKI should
ideally be diagnosed on the basis of clinically important adverse
effects instead of a simple creatinine level elevation.
CONCLUSIONS
Among patients with acute ischemic stroke who underwent CTA
and cerebral angiography in the ED, those with a baseline eGFR
of,30mL/min/1.73 m2 had a higher incidence of PC-AKI com-
pared with those with other eGFR levels. After we adjusted for
risk factors of PC-AKI, the risk of PC-AKI was high in the group
with a baseline eGFR of,43mL/min/1.73 m2. Hence, physicians
could consider noncontrast CT and MR imaging/MRA testing
for the patients in this group. However, because PC-AKI was not
associated with fatal adverse effects in this study, it is recom-
mended that patients suspected of having a stroke be actively
managed with respect to neurovascular function on the basis of
risk/benefit analyses.
REFERENCES
1. Brinjikji W, Demchuk AM, Murad MH, et al. Neurons over neph-
rons: systematic review and meta-analysis of contrast-induced ne-
phropathy in patients with acute stroke. Stroke 2017;48:1862–68
CrossRef Medline
2. Demel SL, Grossman AW, Khoury JC, et al. Association between
acute kidney disease and intravenous dye administration in
patients with acute stroke: a population-based study. Stroke
2017;48:835–39 CrossRef Medline
3. Powers WJ, Rabinstein AA, Ackerson T, et al; American Heart
Association Stroke Council. 2018 guidelines for the early manage-
ment of patients with acute ischemic stroke: a guideline for health-
care professionals from the American Heart Association/American
Stroke Association. Stroke 2018;49:e46–110 CrossRef Medline
4. Esteban JM, Cervera V. Perfusion CT and angio CT in the assess-
ment of acute stroke.Neuroradiology 2004;46:705–15 CrossRef Medline
5. Wildermuth S, Knauth M, Brandt T, et al. Role of CT angiography
in patient selection for thrombolytic therapy in acute hemispheric
stroke. Stroke 1998;29:935–38 CrossRef Medline
6. van den Berg LA, Dijkgraaf MG, Berkhemer OA, et al; MR CLEAN
Investigators. Two-year outcome after endovascular treatment for
FIG 2. Receiver operating characteristic (ROC) curves showing the
probability of PC-AKI. The ROC curve was drawn for PC-AKI predic-
tion probabilities using significant variables from the multivariate
analysis. Baseline eGFR: ROC curve drawn on the basis of the baseline
eGFR variables. eGFR is in milliliter/minute/1.73 m2. AUC indicates
area under the curve.
AJNR Am J Neuroradiol 41:632–36 Apr 2020 www.ajnr.org 635
acute ischemic stroke. N Engl J Med 2017;376:1341–49 CrossRef
Medline
7. Jovin TG, Chamorro A, Cobo E, et al; REVASCAT Trial
Investigators. Thrombectomy within 8 hours after symptom
onset in ischemic stroke. N Engl J Med 2015;372:2296–2306
CrossRef Medline
8. Fransen PS, Berkhemer OA, Lingsma HF, et al; Multicenter
Randomized Clinical Trial of Endovascular Treatment of Acute
Ischemic Stroke in the Netherlands Investigators. Time to reperfu-
sion and treatment effect for acute ischemic stroke: a randomized
clinical trial. JAMA Neurol 2016;73:190–96 CrossRef Medline
9. Jia ZY, Wang SX, Zhao LB, et al. Risk of acute kidney injury with
consecutive, multidose use of iodinated contrast in patients with
acute ischemic stroke. AJNR Am J Neuroradiol 2019;40:652–54
CrossRef Medline
10. Hall SL, Munich SA, Cress MC, et al. Risk of acute kidney injury
associated with neuroimaging obtained during triage and treat-
ment of patients with acute ischemic stroke symptoms. J
Neurointerv Surg 2016;8:1231–34 CrossRef Medline
11. Sharma J, Nanda A, Jung RS, et al. Risk of contrast-induced ne-
phropathy in patients undergoing endovascular treatment of acute
ischemic stroke. J Neurointerv Surg 2013;5:543–55 CrossRef Medline
12. Tao Y, DongW, Li Z, et al. Proteinuria as an independent risk factor
for contrast-induced acute kidney injury and mortality in patients
with stroke undergoing cerebral angiography. J Neurointerv Surg
2017;9:445–48 CrossRef Medline
13. Ang TE, Bivard A, Levi C, et al. Multi-modal CT in acute stroke:
wait for a serum creatinine before giving intravenous contrast?
No! Int J Stroke 2015;10:1014–17 CrossRef Medline
14. Lima FO, Lev MH, Levy RA, et al. Functional contrast-enhanced CT
for evaluation of acute ischemic stroke does not increase the risk
of contrast-induced nephropathy. AJNR Am J Neuroradiol 2010;31:
817–21 CrossRef Medline
15. Ehrlich ME, Turner HL, Currie LJ, et al. Safety of computed to-
mographic angiography in the evaluation of patients with acute
stroke: a single-center experience. Stroke 2016;47:2045–50 CrossRef
Medline
16. Wilhelm-Leen E, Montez-Rath ME, Chertow G. Estimating the risk
of radiocontrast-associated nephropathy. J Am Soc Nephrol
2017;28:653–59 CrossRef Medline
17. McDonald RJ, McDonald JS, Newhouse JH, et al. Controversies in
contrast material-induced acute kidney injury: closing in on the
truth? Radiology 2015;277:627–32 CrossRef Medline
18. Molen A, Reimer P, Dekkers IA, et al. Post-contrast acute kidney
injury, Part 1: definition, clinical features, incidence, role of contrast
medium and risk factors. Eur Radiol 2018;28:2845–55 CrossRef
Medline
19. Barrett BJ, Parfrey PS. Prevention of nephrotoxicity induced by
radiocontrast agents. N Engl J Med 1994;331:1449–50 CrossRef
Medline
20. Feigin VL, Lawes CM, Bennett DA, et al. Stroke epidemiology: a
review of population-based studies of incidence, prevalence, and
case-fatality in the late 20th century. Lancet Neurol 2003;2:43–53
CrossRef Medline
21. Grysiewicz RA, Thomas K, Pandey DK. Epidemiology of ischemic
and hemorrhagic stroke: incidence, prevalence, mortality, and risk
factors. Neurol Clin 2008;26:871–95, vii CrossRef Medline
22. Prencipe M, Culasso F, Rasura M, et al. Long-term prognosis after a
minor stroke: 10-year mortality and major stroke recurrence rates
in a hospital-based cohort. Stroke 1998;29:126–32 CrossRef Medline
23. Mair G, Wardlaw JM. Imaging of acute stroke prior to treatment:
current practice and evolving techniques. Br J Radiol 2014;87:20140216
CrossRef Medline
24. Lev MH, Farkas J, Rodriguez VR, et al. CT angiography in the rapid
triage of patients with hyperacute stroke to intraarterial thrombol-
ysis: accuracy in the detection of large vessel thrombus. J Comput
Assist Tomogr 2001;25:520–28 CrossRef Medline
25. Davenport MS, Khalatbari S, Cohan RH, et al. Contrast material-
induced nephrotoxicity and intravenous low-osmolality iodinated
contrast material: risk stratification by using estimated glomerular
filtration rate. Radiology 2013;268:719–28 CrossRef Medline
26. Weisbord SD, Gallagher M, Jneid H, et al; PRESERVE Trial Group.
Outcomes after angiography with sodium bicarbonate and acetyl-
cysteine. N Engl J Med 2018;378:603–14 CrossRef Medline
27. Partovi S, Trischman T, Kang PS. Lessons learned from the
PRESERVE trial. Br J Radiol 2018;91:20180092 CrossRef
636 Myung Apr 2020 www.ajnr.org
